Catenaa, Monday, June 16, 2025- US drugmakers have signed 14 deals potentially worth $18.3 billion through June to license drugs from China-based companies.  A report by Reuters said on Monday that US drugmakers are licensing molecules from China for potential new medicines at an accelerating pace, betting they can turn upfront payments of as little […]